BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28447278)

  • 21. Childhood hemangiopericytoma: review of St Jude Children's Research Hospital.
    Fernandez-Pineda I; Parida L; Jenkins JJ; Davidoff AM; Rao BN; Rodriguez-Galindo C
    J Pediatr Hematol Oncol; 2011 Jul; 33(5):356-9. PubMed ID: 21602721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The status of MGMT protein expression is a prognostic factor for meningeal hemangiopericytoma: a clinicopathologic and immunohistochemical study of 12 cases at a single institution.
    Chang IW; Lin JW; Wu YT
    J Neurooncol; 2011 Dec; 105(3):563-72. PubMed ID: 21667225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of recurrent intracranial hemangiopericytoma.
    Rutkowski MJ; Bloch O; Jian BJ; Chen C; Sughrue ME; Tihan T; Barani IJ; Berger MS; McDermott MW; Parsa AT
    J Clin Neurosci; 2011 Nov; 18(11):1500-4. PubMed ID: 21917462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemangiopericytoma: Radical resection remains the cornerstone of therapy.
    Ramakrishna R; Rostomily R; Sekhar L; Rockhill J; Ferreira M
    J Clin Neurosci; 2014 Apr; 21(4):612-5. PubMed ID: 24231562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature.
    Hall WA; Ali AN; Gullett N; Crocker I; Landry JC; Shu HK; Prabhu R; Curran W
    Cancer; 2012 Nov; 118(21):5331-8. PubMed ID: 22517327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of mortality following treatment of intracranial hemangiopericytoma.
    Rutkowski MJ; Sughrue ME; Kane AJ; Aranda D; Mills SA; Barani IJ; Parsa AT
    J Neurosurg; 2010 Aug; 113(2):333-9. PubMed ID: 20367074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcome and prognostic factors of head and neck hemangiopericytoma: meta-analysis.
    Wushou A; Miao XC; Shao ZM
    Head Neck; 2015 Nov; 37(11):1685-90. PubMed ID: 24954602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Outcome and Prognostic Factors After Repeated Surgeries for Intracranial Hemangiopericytomas.
    Wang W; Zhang GJ; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2017 Nov; 107():495-505. PubMed ID: 28823664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment outcome and prognosis of head and neck hemangiopericytoma].
    Wushou A; Miao X; Zhao Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(23):1855-9. PubMed ID: 25980156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and prognostic analysis of recurrent hemangiopericytoma in the central nervous system: a review of 46 cases.
    Tian R; Hao S; Hou Z; Bian L; Zhang Y; Wu W; Xu F; Li H; Liu B
    J Neurooncol; 2013 Oct; 115(1):53-9. PubMed ID: 23824534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solitary Fibrous Tumor/Hemangiopericytoma Dichotomy Revisited: A Restless Family of Neoplasms in the CNS.
    Yalcin CE; Tihan T
    Adv Anat Pathol; 2016 Mar; 23(2):104-11. PubMed ID: 26849816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.
    Fürtjes G; Köchling M; Peetz-Dienhart S; Wagner A; Heß K; Hasselblatt M; Senner V; Stummer W; Paulus W; Brokinkel B
    J Neurooncol; 2016 Oct; 130(1):79-87. PubMed ID: 27465278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracranial hemangiopericytoma with extracranial metastasis occurring after 22 years.
    Suzuki H; Haga Y; Oguro K; Shinoda S; Masuzawa T; Kanai N
    Neurol Med Chir (Tokyo); 2002 Jul; 42(7):297-300. PubMed ID: 12160309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of multiple angiogenic signaling pathways in hemangiopericytoma.
    Pierscianek D; Michel A; Hindy NE; Keyvani K; Dammann P; Oezkan N; Mueller O; Sure U; Zhu Y
    Brain Tumor Pathol; 2016 Jul; 33(3):200-8. PubMed ID: 26951238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CNS Hemangiopericytoma: A Systematic Review of 523 Patients.
    Ghose A; Guha G; Kundu R; Tew J; Chaudhary R
    Am J Clin Oncol; 2017 Jun; 40(3):223-227. PubMed ID: 25350465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature.
    Soyuer S; Chang EL; Selek U; McCutcheon IE; Maor MH
    Cancer; 2004 Apr; 100(7):1491-7. PubMed ID: 15042684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional hemangiopericytoma: modern analysis of outcome.
    Espat NJ; Lewis JJ; Leung D; Woodruff JM; Antonescu CR; Shia J; Brennan MF
    Cancer; 2002 Oct; 95(8):1746-51. PubMed ID: 12365023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical management and survival of patients with central nervous system hemangiopericytoma in the National Cancer Database.
    Trifiletti DM; Mehta GU; Grover S; Sheehan JP
    J Clin Neurosci; 2017 Oct; 44():169-174. PubMed ID: 28711294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemangiopericytomas in the spine: clinical features, classification, treatment, and long-term follow-up in 26 patients.
    Liu HG; Yang AC; Chen N; Yang J; Qiu XG; Zhang JG
    Neurosurgery; 2013 Jan; 72(1):16-24; discussion 24. PubMed ID: 23147785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic breast cancer subtypes and central nervous system metastases.
    Aversa C; Rossi V; Geuna E; Martinello R; Milani A; Redana S; Valabrega G; Aglietta M; Montemurro F
    Breast; 2014 Oct; 23(5):623-8. PubMed ID: 24993072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.